The trial is a multi-centric, randomised, open label clinical study to evaluate the efficacy, safety and tolerability of Niclosamide for treating hospitalised COVID-19 patients.
Much of the recent emphasis on planting trees comes from international agencies from the Global North, and assumes that tree-less areas store little carbon.
The Nobel laureate has raised two issues to support his controversial views: that vaccines are driving the creation of mutants and antibody-dependent enhancement.
Virologist Shahid Jameel quits Centre’s panel on genome sequencing
Last week, Jameel had written a piece on the second wave of coronavirus in the New York Times .
By PTI| Published: 17th May 2021 1:40 pm IST Noted virologist Dr Shahid Jameel (Photo: commons.wikimedia.org)
New Delhi: Days after pointing out that scientists are facing “stubborn resistance to evidence-based policy making”, noted virologist Shahid Jameel quit as the head of INSACOG, a central government panel which conducts genome sequencing of coronavirus.
Jameel announced his plan to step down in a meeting of INSACOG held on Friday, said two officials who were part of it.